Seeing Is Believing
Currently out of the existing stock ratings of Etzer Darout, 82 are a BUY (71.3%), 33 are a HOLD (28.7%).
Analyst Etzer Darout, currently employed at GUGGENHEIM, carries an average stock price target met ratio of 50.16% that have a potential upside of 45.91% achieved within 128 days. Previously, Etzer Darout worked at BMO.
Etzer Darout’s has documented 224 price targets and ratings displayed on 26 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on IVA, Inventiva Sa at 04-Apr-2025.
Analyst best performing recommendations are on FPRX (FIVE PRIME THERAPEUTICS).
The best stock recommendation documented was for MGNX (MACROGENICS) at 7/11/2022. The price target of $4 was fulfilled within 2 days with a profit of $0.45 (12.68%) receiving and performance score of 63.38.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$10
$6.46 (182.49%)
$7
1 months 5 days ago
(19-Mar-2025)
0/3 (0%)
$4.76 (90.84%)
Buy
$6
$2.46 (69.49%)
$6
8 months 8 days ago
(16-Aug-2024)
2/4 (50%)
$2.4 (66.67%)
200
Buy
$8
$4.46 (125.99%)
$8
1 years ago
(24-Apr-2024)
1/6 (16.67%)
$5.55 (226.53%)
720
Hold
2 years 9 months 17 days ago
(07-Jul-2022)
0/2 (0%)
$17.96 (178.88%)
Buy
$11
$8.42 (326.36%)
$14
3 years 9 months 25 days ago
(30-Jun-2021)
0/2 (0%)
$6.82 (124.75%)
Which stock is Etzer Darout is most bullish on?
Which stock is Etzer Darout is most reserved on?
What Year was the first public recommendation made by Etzer Darout?